CD Protein Inhibitors Immunotherapy Immune Checkpoint Inhibitors Tyrosine Kinase Inhibitors Interleukins Chemotherapy DNA | B Acute Lymphoblastic Leukemia | Non-Hodgkin’s Lymphoma | Follicular Lymphoma | Diffuse Large B Cell Lymphoma | Acute Lymphocytic Leukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Mantle Cell Lymphoma |
---|---|---|---|---|---|---|---|---|
CTX110 | ||||||||
blinatumomab | ||||||||
acalabrutinib + axicabtagene ciloleucel | ||||||||
tisagenlecleucel-T | ||||||||
A-319 | ||||||||
nivolumab + blinatumomab | ||||||||
YT-19 | ||||||||
PBCAR0191 | ||||||||
pCAR-19B | ||||||||
nivolumab + ipilimumab + blinatumomab | ||||||||
SGN-CD19B | ||||||||
FT596 | ||||||||
ISIKOK-19 | ||||||||
T-lymphocyte cell therapy | ||||||||
CAR-T immunotherapy |